Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model

Background: Antipsychotic monotherapy or polypharmacy (concurrent use of two or more antipsychotics) are used for treating patients with psychiatric disorders (PDs). Usually, antipsychotic monotherapy has a lower cost than polypharmacy. This study aimed to predict the cost of antipsychotic medicatio...

Full description

Bibliographic Details
Main Authors: Arash Mirabzadeh, Enayatollah Bakhshi, Mohamad Reza Khodae, Mohamad Reza Kooshesh, Bibi Riahi Mahabadi, Hossein Mirabzadeh, Akbar Biglarian
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=9;spage=782;epage=785;aulast=Mirabzadeh
id doaj-150308cca832459f8f862611a8d7fc46
record_format Article
spelling doaj-150308cca832459f8f862611a8d7fc462020-11-24T21:57:26ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362013-01-01189782785Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network modelArash MirabzadehEnayatollah BakhshiMohamad Reza KhodaeMohamad Reza KoosheshBibi Riahi MahabadiHossein MirabzadehAkbar BiglarianBackground: Antipsychotic monotherapy or polypharmacy (concurrent use of two or more antipsychotics) are used for treating patients with psychiatric disorders (PDs). Usually, antipsychotic monotherapy has a lower cost than polypharmacy. This study aimed to predict the cost of antipsychotic medications (AM) of psychiatric patients in Iran. Materials and Methods: For this purpose, 790 patients with PDs who were discharged between June and September 2010 were selected from Razi Psychiatric Hospital, Tehran, Iran. For cost prediction of AM of PD, neural network (NN) and multiple linear regression (MLR) models were used. Analysis of data was performed with R 2.15.1 software. Results: Mean ± standard deviation (SD) of the duration of hospitalization (days) in patients who were on monotherapy and polypharmacy was 31.19 ± 15.55 and 36.69 ± 15.93, respectively (P < 0.001). Mean and median costs of medication for monotherapy (n = 507) were $8.25 and $6.23 and for polypharmacy (n =192) were $13.30 and $9.48, respectively (P = 0.001). The important variables for cost prediction of AM were duration of hospitalization, type of treatment, and type of psychiatric ward in the MLR model, and duration of hospitalization, type of diagnosed disorder, type of treatment, age, Chlorpromazine dosage, and duration of disorder in the NN model. Conclusion: Our findings showed that the artificial NN (ANN) model can be used as a flexible model for cost prediction of AM.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=9;spage=782;epage=785;aulast=MirabzadehLinear regressionneural networkspsychiatric disorderstreatment cost
collection DOAJ
language English
format Article
sources DOAJ
author Arash Mirabzadeh
Enayatollah Bakhshi
Mohamad Reza Khodae
Mohamad Reza Kooshesh
Bibi Riahi Mahabadi
Hossein Mirabzadeh
Akbar Biglarian
spellingShingle Arash Mirabzadeh
Enayatollah Bakhshi
Mohamad Reza Khodae
Mohamad Reza Kooshesh
Bibi Riahi Mahabadi
Hossein Mirabzadeh
Akbar Biglarian
Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
Journal of Research in Medical Sciences
Linear regression
neural networks
psychiatric disorders
treatment cost
author_facet Arash Mirabzadeh
Enayatollah Bakhshi
Mohamad Reza Khodae
Mohamad Reza Kooshesh
Bibi Riahi Mahabadi
Hossein Mirabzadeh
Akbar Biglarian
author_sort Arash Mirabzadeh
title Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
title_short Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
title_full Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
title_fullStr Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
title_full_unstemmed Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
title_sort cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Medical Sciences
issn 1735-1995
1735-7136
publishDate 2013-01-01
description Background: Antipsychotic monotherapy or polypharmacy (concurrent use of two or more antipsychotics) are used for treating patients with psychiatric disorders (PDs). Usually, antipsychotic monotherapy has a lower cost than polypharmacy. This study aimed to predict the cost of antipsychotic medications (AM) of psychiatric patients in Iran. Materials and Methods: For this purpose, 790 patients with PDs who were discharged between June and September 2010 were selected from Razi Psychiatric Hospital, Tehran, Iran. For cost prediction of AM of PD, neural network (NN) and multiple linear regression (MLR) models were used. Analysis of data was performed with R 2.15.1 software. Results: Mean ± standard deviation (SD) of the duration of hospitalization (days) in patients who were on monotherapy and polypharmacy was 31.19 ± 15.55 and 36.69 ± 15.93, respectively (P < 0.001). Mean and median costs of medication for monotherapy (n = 507) were $8.25 and $6.23 and for polypharmacy (n =192) were $13.30 and $9.48, respectively (P = 0.001). The important variables for cost prediction of AM were duration of hospitalization, type of treatment, and type of psychiatric ward in the MLR model, and duration of hospitalization, type of diagnosed disorder, type of treatment, age, Chlorpromazine dosage, and duration of disorder in the NN model. Conclusion: Our findings showed that the artificial NN (ANN) model can be used as a flexible model for cost prediction of AM.
topic Linear regression
neural networks
psychiatric disorders
treatment cost
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=9;spage=782;epage=785;aulast=Mirabzadeh
work_keys_str_mv AT arashmirabzadeh costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
AT enayatollahbakhshi costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
AT mohamadrezakhodae costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
AT mohamadrezakooshesh costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
AT bibiriahimahabadi costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
AT hosseinmirabzadeh costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
AT akbarbiglarian costpredictionofantipsychoticmedicationofpsychiatricdisorderusingartificialneuralnetworkmodel
_version_ 1725855571353010176